{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T16:11:35Z","timestamp":1783959095268,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Insulin resistance (IR) is linked to overactive bladder (OAB), with chronic inflammation serving as a common pathophysiological mechanism in both conditions. As a robust marker of IR, estimated glucose disposal rate (eGDR) was selected as the exposure variable to examine its relationship with OAB, with a specific focus on the mediating role of inflammation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a cross-sectional study using data from the 2005\u20132018 National Health and Nutrition Examination Survey (NHANES). We utilized weighted logistic regression to assess the association of eGDR with OAB, while restricted cubic splines (RCS) helped characterize potential nonlinear patterns in this relationship. Subgroup analyses and interaction tests were performed to assess heterogeneity in the eGDR-OAB association across different subgroups. Mediation analysis was used to explore whether systemic inflammatory biomarkers statistically explain part of the eGDR-OAB association, while acknowledging that causal inference is limited by the cross-sectional design.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      31,351 participants were included in this study, of whom 6,356 (20.27%) were diagnosed with OAB. In the fully adjusted Model, each one-unit increment in eGDR was associated with a 11% reduction in OAB risk (OR\u2009=\u20090.89; 95% CI: 0.87\u20130.91;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and a 48% decreased risk of OAB for the highest eGDR quartile (Q4) compared to the lowest quartile (Q1) (OR\u2009=\u20090.52; 95% CI: 0.42\u20130.64;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). RCS analysis showed a significant nonlinear inverse association between eGDR and OAB, and this association was consistently observed across nearly all subgroups. Mediation analyses revealed that systemic inflammatory biomarkers statistically mediated the relationship between eGDR and OAB, explaining approximately 0.64\u20133.15% of the total effect, suggesting that inflammation accounts for only a small fraction of the eGDR\u2013OAB association, while other mechanisms (e.g., autonomic dysfunction, microvascular damage, urothelial changes) likely contribute more substantially.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our research confirmed the correlation between eGDR, inflammation and OAB. The potential mediating effect of inflammation between eGDR and OAB provides a meaningful direction for future research and targeted interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13098-026-02182-4","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T21:03:11Z","timestamp":1779224591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Associations of estimated glucose disposal rate and overactive bladder and the potential mediating role of systemic inflammation: NHANES 2005\u20132018"],"prefix":"10.1186","volume":"18","author":[{"given":"Xiaodan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanrong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghui","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangbao","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"issue":"2","key":"2182_CR1","first-page":"179","volume":"21","author":"P Abrams","year":"2002","unstructured":"Abrams P, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol. 2002;21(2):179\u201383.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2182_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.maturitas.2010.03.010","volume":"66","author":"E Henderson","year":"2010","unstructured":"Henderson E, Drake M. Overactive bladder. Maturitas. 2010;66(3):257\u201362.","journal-title":"Maturitas"},{"issue":"8","key":"2182_CR3","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s00192-024-06029-2","volume":"36","author":"L Zhang","year":"2025","unstructured":"Zhang L, et al. Global Prevalence of Overactive Bladder: A Systematic Review and Meta-analysis. Int Urogynecol J. 2025;36(8):1547\u201366.","journal-title":"Int Urogynecol J"},{"issue":"1","key":"2182_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/1359105314522084","volume":"21","author":"D Kinsey","year":"2016","unstructured":"Kinsey D, et al. The psychological impact of overactive bladder: A systematic review. J Health Psychol. 2016;21(1):69\u201381.","journal-title":"J Health Psychol"},{"issue":"1","key":"2182_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11884-016-0344-9","volume":"11","author":"WS Reynolds","year":"2016","unstructured":"Reynolds WS, Fowke J, Dmochowski R. The Burden of Overactive Bladder on US Public Health. Curr Bladder Dysfunct Rep. 2016;11(1):8\u201313.","journal-title":"Curr Bladder Dysfunct Rep"},{"issue":"4","key":"2182_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.5213\/inj.2012.16.4.181","volume":"16","author":"H Uzun","year":"2012","unstructured":"Uzun H, et al. Association of Insulin Resistance with Overactive Bladder in Female Patients. Int Neurourol J. 2012;16(4):181\u20136.","journal-title":"Int Neurourol J"},{"key":"2182_CR7","doi-asserted-by":"crossref","unstructured":"Hsu L et al. Metabolic Syndrome and Overactive Bladder Syndrome May Share Common Pathophysiologies. Biomedicines. 2022;10(8):1957.","DOI":"10.3390\/biomedicines10081957"},{"issue":"3","key":"2182_CR8","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2337\/diacare.19.3.278","volume":"19","author":"D Elahi","year":"1996","unstructured":"Elahi D. In praise of the hyperglycemic clamp. A method for assessment of beta-cell sensitivity and insulin resistance. Diabetes Care. 1996;19(3):278\u201386.","journal-title":"Diabetes Care"},{"key":"2182_CR9","doi-asserted-by":"crossref","unstructured":"Matthews DR et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u20139.","DOI":"10.1007\/BF00280883"},{"issue":"7","key":"2182_CR10","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347\u201351.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2182_CR11","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.2337\/dc12-1693","volume":"36","author":"EJ Epstein","year":"2013","unstructured":"Epstein EJ, et al. Use of the Estimated Glucose Disposal Rate as a Measure of Insulin Resistance in an Urban Multiethnic Population With Type 1 Diabetes. Diabetes Care. 2013;36(8):2280\u20135.","journal-title":"Diabetes Care"},{"key":"2182_CR12","doi-asserted-by":"publisher","first-page":"1610140","DOI":"10.3389\/fendo.2025.1610140","volume":"16","author":"B Chen","year":"2025","unstructured":"Chen B, et al. Triglyceride-glucose index and overactive bladder syndrome: evidence from the NHANES 2005\u20132018. Front Endocrinol (Lausanne). 2025;16:1610140.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2182_CR13","doi-asserted-by":"publisher","first-page":"112128","DOI":"10.1016\/j.diabres.2025.112128","volume":"223","author":"Y Huang","year":"2025","unstructured":"Huang Y, et al. Association between different triglyceride glucose index-related indicators and overactive bladder. Diabetes Res Clin Pract. 2025;223:112128.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"2182_CR14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nri2925","volume":"11","author":"MY Donath","year":"2011","unstructured":"Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11(2):98\u2013107.","journal-title":"Nat Rev Immunol"},{"key":"2182_CR15","doi-asserted-by":"crossref","unstructured":"Wang CC, Jiang YH, Kuo HC. The Pharmacological Mechanism of Diabetes Mellitus-Associated Overactive Bladder and Its Treatment with Botulinum Toxin A. Toxins. 2020;12(3):186.","DOI":"10.3390\/toxins12030186"},{"key":"2182_CR16","doi-asserted-by":"publisher","first-page":"111575","DOI":"10.1016\/j.diabres.2024.111575","volume":"209","author":"J Zhang","year":"2024","unstructured":"Zhang J, et al. Association between inflammatory biomarkers and mortality in individuals with type 2 diabetes: NHANES 2005\u20132018. Diabetes Res Clin Pract. 2024;209:111575.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2182_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-025-02698-5","volume":"24","author":"J Liu","year":"2025","unstructured":"Liu J, et al. Oxidative stress and inflammation mediate the adverse effects of cadmium exposure on all-cause and cause-specific mortality in patients with diabetes and prediabetes. Cardiovasc Diabetol. 2025;24(1):1\u201317.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"2182_CR18","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.juro.2007.03.133","volume":"178","author":"JGBA C","year":"2007","unstructured":"C JGBA, et al. Validation of the Overactive Bladder Symptom Score. J Urol. 2007;178(2):543\u20137.","journal-title":"J Urol"},{"issue":"12","key":"2182_CR19","doi-asserted-by":"publisher","first-page":"8885","DOI":"10.1097\/JS9.0000000000003214","volume":"111","author":"J Wang","year":"2025","unstructured":"Wang J, et al. Urinary heavy metal burden and overactive bladder risk: a cross-sectional study based on NHANES 2005\u20132018. Int J Surg. 2025;111(12):8885\u201395.","journal-title":"Int J Surg"},{"issue":"6","key":"2182_CR20","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.clnu.2024.03.027","volume":"43","author":"F Tang","year":"2024","unstructured":"Tang F, et al. The association between wet overactive bladder and consumption of tea, coffee, and caffeine: Results from 2005\u20132018 National Health and Nutrition Examination Survey. Clin Nutr. 2024;43(6):1261\u20139.","journal-title":"Clin Nutr"},{"issue":"1","key":"2182_CR21","doi-asserted-by":"publisher","first-page":"16280","DOI":"10.1038\/s41598-025-01272-z","volume":"15","author":"T Wu","year":"2025","unstructured":"Wu T, Xu B. The relationship between physical activity and overactive bladder among American adults: a cross-sectional study from NHANES 2007\u20132018. Sci Rep. 2025;15(1):16280.","journal-title":"Sci Rep"},{"issue":"25","key":"2182_CR22","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"Third Report of the National Cholesterol Education Program (NCEP)","year":"2002","unstructured":"Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143\u2013421.","journal-title":"Circulation"},{"issue":"1","key":"2182_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12944-024-02005-3","volume":"23","author":"AH Behnoush","year":"2024","unstructured":"Behnoush AH, et al. Triglyceride-glucose index and obstructive sleep apnea: a systematic review and meta-analysis. Lipids Health Disease. 2024;23(1):4.","journal-title":"Lipids Health Disease"},{"key":"2182_CR24","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/dom.13110","volume":"20","author":"T Nystrm","year":"2018","unstructured":"Nystrm T, et al. Estimated glucose disposal rate predicts mortality in adults with type 1 diabetes. Diabetes Obes Metabolism. 2018;20:556\u201363.","journal-title":"Diabetes Obes Metabolism"},{"issue":"5","key":"2182_CR25","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.2337\/diacare.26.5.1374","volume":"26","author":"J Trevor","year":"2003","unstructured":"Trevor J, Orchard JCOJ. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care. 2003;26(5):1374\u20139.","journal-title":"Diabetes Care"},{"key":"2182_CR26","doi-asserted-by":"publisher","first-page":"117955142513727","DOI":"10.1177\/11795514251372702","volume":"18","author":"S Shojaei","year":"2025","unstructured":"Shojaei S, et al. Linking Estimated Glucose Disposal Rate to Major Adverse Cardio-Cerebrovascular Events in Populations With and Without Diabetes: A Systematic Review and Meta-Analysis. Clin Med insights Endocrinol diabetes. 2025;18:11795514251372702\u201311795514251372702.","journal-title":"Clin Med insights Endocrinol diabetes"},{"issue":"6","key":"2182_CR27","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.eururo.2019.02.038","volume":"75","author":"B Peyronnet","year":"2019","unstructured":"Peyronnet B, et al. A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment. Eur Urol. 2019;75(6):988\u20131000.","journal-title":"Eur Urol"},{"issue":"1","key":"2182_CR28","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s13098-025-01883-6","volume":"17","author":"Z Liu","year":"2025","unstructured":"Liu Z, et al. Relationship between metabolic syndrome and overactive bladder: insights from the NHANES and Mendelian randomization study. Diabetol Metab Syndr. 2025;17(1):350.","journal-title":"Diabetol Metab Syndr"},{"issue":"9","key":"2182_CR29","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1113\/jphysiol.2013.251843","volume":"591","author":"LO Leiria","year":"2013","unstructured":"Leiria LO, et al. Insulin relaxes bladder via PI3K\/AKT\/eNOS pathway activation in mucosa: unfolded protein response-dependent insulin resistance as a cause of obesity-associated overactive bladder. J Physiol. 2013;591(9):2259\u201373.","journal-title":"J Physiol"},{"issue":"1","key":"2182_CR30","doi-asserted-by":"publisher","first-page":"8202","DOI":"10.1038\/s41598-021-87505-3","volume":"11","author":"W Lee","year":"2021","unstructured":"Lee W, et al. Tadalafil ameliorates bladder overactivity by restoring insulin-activated detrusor relaxation via the bladder mucosal IRS\/PI3K\/AKT\/eNOS pathway in fructose-fed rats. Sci Rep. 2021;11(1):8202.","journal-title":"Sci Rep"},{"issue":"3","key":"2182_CR31","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jfma.2022.09.013","volume":"122","author":"W Lee","year":"2023","unstructured":"Lee W, et al. Impaired insulin signaling at the bladder mucosa facilitates metabolic syndrome-associated bladder overactivity in rats with maternal and post-weaning fructose exposure. J Formos Med Assoc. 2023;122(3):258\u201366.","journal-title":"J Formos Med Assoc"},{"issue":"7203","key":"2182_CR32","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature07201","volume":"454","author":"R Medzhitov","year":"2008","unstructured":"Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454(7203):428\u201335.","journal-title":"Nature"},{"key":"2182_CR33","doi-asserted-by":"publisher","first-page":"1386639","DOI":"10.3389\/fendo.2024.1386639","volume":"15","author":"Q He","year":"2024","unstructured":"He Q, et al. Diabetes mellitus, systemic inflammation and overactive bladder. Front Endocrinol (Lausanne). 2024;15:1386639.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2182_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2478\/jce-2021-0014","volume":"7","author":"B Matyas","year":"2021","unstructured":"Matyas B, et al. Biomarkers of Systemic Versus Local Inflammation During the Acute Phase of Myocardial Infarction, as Predictors of Post-infarction Heart Failure. J Cardiovasc Emergencies. 2021;7(3):70\u20136.","journal-title":"J Cardiovasc Emergencies"},{"issue":"6","key":"2182_CR35","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.2337\/diacare.26.6.1922","volume":"26","author":"ZT Bloomgarden","year":"2003","unstructured":"Bloomgarden ZT. Inflammation and insulin resistance. Diabetes Care. 2003;26(6):1922\u20136.","journal-title":"Diabetes Care"},{"issue":"1","key":"2182_CR36","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.trsl.2015.08.011","volume":"167","author":"H Khodabandehloo","year":"2016","unstructured":"Khodabandehloo H, et al. Molecular and cellular mechanisms linking inflammation to insulin resistance and beta-cell dysfunction. Transl Res. 2016;167(1):228\u201356.","journal-title":"Transl Res"},{"key":"2182_CR37","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3389\/fnins.2018.00931","volume":"12","author":"L Grundy","year":"2018","unstructured":"Grundy L, Caldwell A, Brierley SM. Mechanisms Underlying Overactive Bladder and Interstitial Cystitis\/Painful Bladder Syndrome. Front Neurosci. 2018;12:931.","journal-title":"Front Neurosci"},{"issue":"20","key":"2182_CR38","doi-asserted-by":"publisher","first-page":"11103","DOI":"10.3390\/ijms252011103","volume":"25","author":"H Lin","year":"2024","unstructured":"Lin H, et al. Effects of Nitric Oxide on Bladder Detrusor Overactivity through the NRF2 and HIF-1alpha Pathways: A Rat Model Induced by Metabolic Syndrome and Ovarian Hormone Deficiency. Int J Mol Sci. 2024;25(20):11103.","journal-title":"Int J Mol Sci"},{"key":"2182_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-publhealth-032315-021402","volume":"37","author":"TJ VanderWeele","year":"2016","unstructured":"VanderWeele TJ. Mediation Analysis: A Practitioner\u2019s Guide. Annu Rev Public Health. 2016;37:17\u201332.","journal-title":"Annu Rev Public Health"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-026-02182-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02182-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02182-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T16:01:58Z","timestamp":1783958518000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13098-026-02182-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2182"],"URL":"https:\/\/doi.org\/10.1186\/s13098-026-02182-4","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The NHANES study protocols were approved by the National Center for Health Statistics (NCHS) Ethics Review Board, and all participants provided written informed consent prior to enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"154"}}